Ad is loading...
MDLOX
Price
$19.44
Change
-$0.06 (-0.31%)
Updated
Nov 15 closing price
RLEFX
Price
$36.11
Change
-$0.33 (-0.91%)
Updated
Nov 15 closing price
Ad is loading...

MDLOX vs RLEFX

Header iconMDLOX vs RLEFX Comparison
Open Charts MDLOX vs RLEFXBanner chart's image
BlackRock Global Allocation Inv A
Price$19.44
Change-$0.06 (-0.31%)
VolumeN/A
CapitalizationN/A
American Funds American Balanced R5E
Price$36.11
Change-$0.33 (-0.91%)
VolumeN/A
CapitalizationN/A
MDLOX vs RLEFX Comparison Chart
Loading...
View a ticker or compare two or three
VS
MDLOX vs. RLEFX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MDLOX is a Buy and RLEFX is a StrongBuy.

FUNDAMENTALS
Fundamentals
RLEFX has more cash in the bank: 236B vs. MDLOX (16.8B). RLEFX pays higher dividends than MDLOX: RLEFX (2.42) vs MDLOX (1.09). MDLOX was incepted earlier than RLEFX: MDLOX (30 years) vs RLEFX (9 years). MDLOX (174.00) and RLEFX (171.00) have comparable annual turnover. RLEFX has a lower initial minimum investment than MDLOX: RLEFX (250) vs MDLOX (1000). RLEFX annual gain was more profitable for investors over the last year : 21.09 vs. MDLOX (12.09). RLEFX return over 5 years is better than : 35.95 vs. MDLOX (2.73).
MDLOXRLEFXMDLOX / RLEFX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence30 years9 years-
Gain YTD5.79914.21141%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets16.8B236B7%
Annual Yield % from dividends1.092.4245%
Returns for 1 year12.0921.0957%
Returns for 3 years-10.8210.95-99%
Returns for 5 years2.7335.958%
Returns for 10 years-4.61N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SKYW111.330.52
+0.47%
SkyWest
TCBK47.59-0.02
-0.04%
TriCo Bancshares
WIT6.72-0.07
-1.03%
Wipro Limited
EDAP2.45-0.07
-2.78%
EDAP TMS SA
ELEV0.53-0.05
-8.41%
Elevation Oncology